Human trials for Covaxin begin in Chennai

Human trials for Covaxin begin in Chennai

The first phase of human trials of Covaxin, an indigenous Covid-19 vaccine, began in SRM Medical College Hospital and Research Centre in Chennai at 9 AM on Thursday. SRM is one of the 12 institutions that have been chosen for conducting human trials.

Covaxine has been developed by Bharat Biotech, a company based in Hyderabad, in collaboration with the Indian Council of Medical Research (ICMR) and National Institute of Virology (NIV).